NCT05938374 2025-12-11SPARE-03Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Completed52 enrolled
NCT03863860 2025-07-03A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer PatientsJiangsu HengRui Medicine Co., Ltd.Phase 3 Completed252 enrolled